electroCore, Inc. Announces Publication of a Voluntary ex-ante Transparency Tender Notice Award by NHS England to Fund Continued Use of gammaCore™ in England
August 24, 2020 07:30 ET
|
electroCore
BASKING RIDGE, N.J., Aug. 24, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the Official Journal of the European...
electroCore Announces Second Quarter Financial Results
August 13, 2020 16:05 ET
|
electroCore
Received EUA and initiated gammaCore Sapphire CV distribution process for certain known or suspected COVID-19 patients experiencing asthma exacerbations Generated sequential increase in revenue ...
electroCore to Announce Second Quarter Ended June 30, 2020 Financial Results on Thursday, August 13
August 06, 2020 16:05 ET
|
electroCore
BASKING RIDGE, N.J., Aug. 06, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced that it will report financial results for the...
electroCore Provides Update on Availability of gammaCore Sapphire™ CV for the Acute Treatment of Asthma Exacerbations in Known or Suspected COVID-19 Patients
July 30, 2020 16:01 ET
|
electroCore
BASKING RIDGE, N.J., July 30, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced more information about availability,...
electroCore Announces Non-Invasive Vagus Nerve Stimulation Clinical Update Publication in Cephalalgia
July 28, 2020 08:58 ET
|
electroCore
BASKING RIDGE, N.J., July 28, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a paper, entitled,...
Correction - electroCore Provides Business Update and Select Financial Guidance
July 16, 2020 09:21 ET
|
electroCore
BASKING RIDGE, N.J., July 16, 2020 (GLOBE NEWSWIRE) -- In a release issued under the same headline on July 14, 2020, the company’s cash was incorrectly stated as being as of the end of the first...
electroCore Provides Business Update and Select Financial Guidance
July 14, 2020 16:05 ET
|
electroCore
BASKING RIDGE, N.J., July 14, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today provided an operating and business update as well as...
electroCore Announces FDA Emergency Use Authorization for use of gammaCore Sapphire™ CV for the Acute Treatment of Asthma Exacerbations in Known or Suspected COVID-19 Patients
July 13, 2020 07:00 ET
|
electroCore
BASKING RIDGE, N.J., July 13, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the FDA has issued an Emergency Use...
electroCore to Participate in Three Upcoming Virtual Investor Conferences
July 09, 2020 16:01 ET
|
electroCore
BASKING RIDGE, N.J., July 09, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that Dan Goldberger, Chief Executive...
electroCore, Inc. to Present at Little Grapevine’s G1 Microcap Virtual Conference
May 29, 2020 08:00 ET
|
electroCore
BASKING RIDGE, N.J., May 29, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that that a prerecorded virtual...